Armonica Technologies, LLC

Armonica Technologies is developing a proprietary long-read DNA sequencing platform that is designed to sequence a complete human genome in minutes. The Company’s mission is to become the gold standard of DNA sequencing for precision medicine research applications. Today’s standard genome sequencing approaches require extensive library preparation, and create a massive computational and bioinformatics problem related to reassembling the data set. Armonica’s technology, called optical nanopore sequencing, uses proprietary nanochannels to deliver single DNA molecules through nanopores. Nanopore sequencing produces long DNA strings, or long reads, which provide more accurate identification of genome variations and abnormalities. More information on

Scroll to top